MedTrace Logo

Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery

NCT00926419 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2009-06-23

No results posted yet for this study

Summary

This study aims to assess immunogenicity and safety of nd influence of the delivery system (needle-free injector or syringe with needle) of fractional doses (dose sparing) of two vaccines (Varicella and Hepatitis A vaccines) in children aged 13 to 30 months.

Conditions

  • Varicella
  • Hepatitis A

Interventions

BIOLOGICAL

Varicella Vaccine

Lyophilized Varicella virus vaccine, live, attenuated (Oka-strain)

BIOLOGICAL

Hepatitis A Vaccine

Hepatitis A virus vaccine, inactivated, Single dose

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Glacus S Brito, MD · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Months
Max Age
30 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2009-11-30
Completion
2010-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00926419 on ClinicalTrials.gov